Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-06-15$3.68/sh+3,160$11,640→ 1,420,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-16$3.90/sh+3,000$11,714→ 1,423,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-20$4.14/sh+2,000$8,289→ 1,425,700 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (5)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.19 to $3.99, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.745 to $3.98, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.07 to $4.17, inclusive.
- [F5]These shares are directly owned by Mr. Golestaneh in his personal capacity.